Investors and banks have put pressure on pharmaceutical companies to raise drug prices and explore other means to profit from the coronavirus crisis.
According to The Intercept, the biggest healthcare companies stand to gain billions of dollars in emergency spending on the pandemic, as do banks and investors who invest in them.
Read more here.
